Cancer Therapy Advisor

Cancer Therapy Advisor is a news platform that provides the latest updates and information on cancer treatments and therapies. It covers various types of cancers and offers resources for patients, healthcare professionals, and researchers. The website features news articles, conferences coverage, daily updates, general oncology grand rounds, gynecologic cancer grand rounds, and email newsletters. The content is aimed at keeping readers informed about the latest advancements in cancer therapy.

99%

The Daily's Verdict

This news site is known for its high journalistic standards. It strives to maintain neutrality and transparency in its reporting, and avoids conflicts of interest. It has a reputation for accuracy and rarely gets contradicted on major discrepancies in its reporting.

Bias

100%

Examples:

No current examples available.

Conflicts of Interest

100%

Examples:

No current examples available.

Contradictions

100%

Examples:

No current examples available.

Deceptions

100%

Examples:

No current examples available.

Recent Articles

  • New Non-Surgical Treatment for Skin Cancer: IG-SRT and Advancements in Systemic Therapy

    New Non-Surgical Treatment for Skin Cancer: IG-SRT and Advancements in Systemic Therapy

    Broke On: Thursday, 06 June 2024 New treatment options for skin cancer include Image-Guided Superficial Radiotherapy (IG-SRT), a non-surgical method using low level radiation that's less invasive and leaves the skin intact. Advancements in systemic therapy, such as immunotherapy and targeted therapies, have revolutionized melanoma treatment, increasing median survival from 6 months to nearly 6 years for inoperable stage IV disease. Wearing high SPF sunscreen is crucial for preventing skin cancer and protecting against wrinkles and discoloration.
  • Breast Cancer Patients May Skip Nodal Irradiation After Neoadjuvant Chemotherapy, Study Suggests

    Broke On: Thursday, 07 December 2023 Breast cancer patients who have lymph node-negative disease after neoadjuvant chemotherapy may be able to safely forgo adjuvant regional nodal irradiation (RNI). The 5-year disease-free survival rate was similar among patients who received RNI and those who did not. The lead researcher, Eleftherios Mamounas, disclosed ties to the biopharmaceutical industry.